InconclusiveLaboratory Study -2021
Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases
Classification Results
AI Classification
InconclusiveFine-tuned Classification
N/AAI Classification
InconclusiveFine-tuned Classification
N/AContraception, fertility and inflammatory bowel disease (IBD): a survey of the perspectives of patients, gastroenterologists and women’s healthcare providers
Cannabis use in Crohn’s disease: a systematic review and meta-analysis of randomized controlled trials (RCTs)
Orally Administered CBD/CBG Hemp Extract Reduces Severity of Ulcerative Colitis and Pain in a Murine Model
The Intestinal Microbiota: An Environmental Effector for the Endocannabinoid System and Medicinal Cannabis in Inflammatory Bowel Disease
Characterization of the gut phageome of Japanese patients with ulcerative colitis under endoscopic remission
CANNABINOID MEDICINAL CHEMISTRY HAS VAST IMPACT ON PHARMACOLOGY IN MOUSE AND RAT MODELS OF INFLAMMATORY BOWEL DISEASE (IBD)